Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

Laura E. Targownik; Eric I. Benchimol; Charles N. Bernstein; Harminder Singh; Aruni Tennakoon; Antonio Aviña Zubieta; Stephanie Coward; Jennifer Jones; Gilaad G. Kaplan; M. Ellen Kuenzig; Sanjay K. Murthy; Geoffrey C. Nguyen; Juan Nicolás Peña-Sánchez

doi:10.1093/ecco-jcc/jjaa050

Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

Laura E. Targownik, Eric I. Benchimol, Charles N. Bernstein, Harminder Singh, Aruni Tennakoon, Antonio Aviña Zubieta, Stephanie Coward, Jennifer Jones, Gilaad G. Kaplan, M. Ellen Kuenzig, Sanjay K. Murthy, Geoffrey C. Nguyen, Juan Nicolás Peña-Sánchez

Business, Management and Accounting

科研成果: 期刊稿件 › 文章 › 同行评审

50 引用（Scopus）

源语言	英语
页（从-至）	1354-1363
页数	10
期刊	Journal of Crohn's and Colitis
卷	14
期	10
DOI	https://doi.org/10.1093/ecco-jcc/jjaa050
出版状态	已出版 - 10月 1 2020

!!!ASJC Scopus Subject Areas

肠胃病学

访问文件

10.1093/ecco-jcc/jjaa050

其它文件与链接

引用此

Targownik, L. E., Benchimol, E. I., Bernstein, C. N., Singh, H., Tennakoon, A., Zubieta, A. A., Coward, S., Jones, J., Kaplan, G. G., Kuenzig, M. E., Murthy, S. K., Nguyen, G. C., & Peña-Sánchez, J. N. (2020). Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications. Journal of Crohn's and Colitis, 14(10), 1354-1363. https://doi.org/10.1093/ecco-jcc/jjaa050

Targownik, LE, Benchimol, EI, Bernstein, CN, Singh, H, Tennakoon, A, Zubieta, AA, Coward, S, Jones, J, Kaplan, GG, Kuenzig, ME, Murthy, SK, Nguyen, GC & Peña-Sánchez, JN 2020, 'Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications', Journal of Crohn's and Colitis, 卷 14, 号码 10, 页码 1354-1363. https://doi.org/10.1093/ecco-jcc/jjaa050

@article{22fc9d27d9a2434094c49596a701ccf2,

title = "Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications",

author = "Targownik, {Laura E.} and Benchimol, {Eric I.} and Bernstein, {Charles N.} and Harminder Singh and Aruni Tennakoon and Zubieta, {Antonio Avi{\~n}a} and Stephanie Coward and Jennifer Jones and Kaplan, {Gilaad G.} and Kuenzig, {M. Ellen} and Murthy, {Sanjay K.} and Nguyen, {Geoffrey C.} and Pe{\~n}a-S{\'a}nchez, {Juan Nicol{\'a}s}",

note = "Funding Information: This work was supported through a grant from the Crohn's and Colitis Canada Grants in Aid of Research and the Helmsley Foundation. Publisher Copyright: {\textcopyright} 2020 The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn's and Colitis Organisation. All rights reserved.",

year = "2020",

month = oct,

day = "1",

doi = "10.1093/ecco-jcc/jjaa050",

language = "English",

volume = "14",

pages = "1354--1363",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

AU - Targownik, Laura E.

AU - Benchimol, Eric I.

AU - Bernstein, Charles N.

AU - Singh, Harminder

AU - Tennakoon, Aruni

AU - Zubieta, Antonio Aviña

AU - Coward, Stephanie

AU - Jones, Jennifer

AU - Kaplan, Gilaad G.

AU - Kuenzig, M. Ellen

AU - Murthy, Sanjay K.

AU - Nguyen, Geoffrey C.

AU - Peña-Sánchez, Juan Nicolás

N1 - Funding Information: This work was supported through a grant from the Crohn's and Colitis Canada Grants in Aid of Research and the Helmsley Foundation. Publisher Copyright: © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn's and Colitis Organisation. All rights reserved.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85092680134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092680134&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjaa050

DO - 10.1093/ecco-jcc/jjaa050

M3 - Article

C2 - 32648579

AN - SCOPUS:85092680134

SN - 1873-9946

VL - 14

SP - 1354

EP - 1363

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 10

ER -

Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此